Today: 19 April 2026
Amazon Stock Price Today: Why AMZN Slipped Despite a New AI Deal, Prime Day Shift and EU Court Win
13 March 2026
2 mins read

Amazon Stock Price Today: Why AMZN Slipped Despite a New AI Deal, Prime Day Shift and EU Court Win

NEW YORK, March 13, 2026, 12:36 PM EDT

Amazon.com shares edged down 0.9% to $207.74 around midday Friday after Amazon Web Services announced a new partnership with Cerebras Systems. The arrangement zeros in on inference—the phase where trained AI models generate responses from prompts. “Every customer large or small is on AWS,” Cerebras CEO Andrew Feldman said. Investors seemed to keep their eyes on the price tag of Amazon’s AI expansion. Reuters

That’s a big deal right now, with Amazon tapping markets for a huge sum to fuel its AI expansion. This week, the company sold $37 billion in U.S. bonds and debuted in Europe with a 14.5 billion euro issue, raising the global total to roughly $54 billion. All this comes after Amazon told investors last month its 2026 capital spending would balloon to $200 billion.

Amazon isn’t the only big name tapping the debt markets. Alphabet pulled in around $32 billion last month through U.S. and European bonds, while Oracle has said it’s targeting $45 billion to $50 billion this year to boost its cloud capacity. For context, LSEG data puts Amazon’s 2025 revenue at $716.9 billion with $77.7 billion in net income—figures that help explain why bond buyers came out in force.

Retail’s heating up on a new front. Amazon is shifting Prime Day into late June this year—Bloomberg News flagged the move on Thursday—a notable change from its usual July slot that pushes the high-profile sale into Q2. Last year, U.S. retailers racked up $24.1 billion in online sales over Prime Day’s four-day run. The timing tweak comes as Walmart turns up the pressure in e-commerce and delivery speed.

Amazon notched a legal victory in Europe on Friday as a Luxembourg court tossed out a record privacy fine—746 million euros, or $854.4 million—and kicked the dispute back to regulators. The judges found the watchdog hadn’t adequately examined whether Amazon’s actions were intentional or negligent. Amazon, for its part, said it had “strongly disagreed” with the initial decision. Reuters

Still, worries linger. On Thursday, Italian prosecutors pushed for a trial against Amazon’s European division and four executives, alleging tax evasion totaling roughly 1.2 billion euros—even after Amazon settled with Italy’s tax agency back in December. Meanwhile, rising oil prices and persistent inflation are fueling expectations that the Federal Reserve isn’t cutting rates anytime soon. “Inflation remains elevated, sticky,” said Peter Cardillo of Spartan Capital Securities. Reuters

That goes a long way toward explaining why investors remain on edge. On Feb. 6, Amazon shares dropped 9% after the company unveiled a $200 billion spending plan. At the time, analysts at MoffettNathanson flagged that “the magnitude of the spend” was higher than most had anticipated, and AJ Bell’s Russ Mould cautioned it’s become easier for the major cloud players to fall short. Reuters

So far, Wall Street isn’t biting. The stock barely budged, with investors holding out for evidence that speedier AI, extra leverage, and a juggled retail calendar will actually pay off.

Stock Market Today

  • Peloton (PTON) Shows Signs of Undervaluation Despite Recent Price Surge
    April 18, 2026, 11:42 PM EDT. Peloton Interactive's shares rose 10.4% last week and 32.8% over the past month, closing at $5.10. Despite declines of 16.7% year-to-date and 5.4% over one year, the stock remains down 46.2% over three years and 95% over five years. Analysts highlight Peloton's efforts to reshape its business model and product line as key for future potential. Simply Wall St's Discounted Cash Flow (DCF) valuation estimates Peloton's intrinsic value at $15.58 per share, suggesting shares are 67.3% undervalued. The DCF method forecasts future free cash flows discounted to present value, indicating possible upside amid current market pricing. Investors should weigh these findings alongside ongoing business shifts and risk perceptions.

Latest article

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
Huntington Bancshares Stock Price Today: HBAN Steadies as Bank Backs 2026 Targets, Buybacks
Previous Story

Huntington Bancshares Stock Price Today: HBAN Steadies as Bank Backs 2026 Targets, Buybacks

Occidental Petroleum Stock in Focus as $100 Oil Pushes OXY to $59
Next Story

Occidental Petroleum Stock in Focus as $100 Oil Pushes OXY to $59

Go toTop